Global Patient Blood Management Market, By Unit (Blood Components, Whole Blood), Articles (Instruments, Blood Processing Devices, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic and Testing Instruments, Blood Storage Devices, Accessories, Syringes and Needles, Vials and Tubes, Blood Bank and Transfusion Software, Software, Assay Kits, Slide Staining, Blood Typing Reagents, Culture Media, Reagents and Kits, Blood Bags), End User (Hospitals, Blood Banks) – Industry Trends and Forecast to 2029
Patient Blood Management Market Analysis and Size
Better management results in patients typically needing fewer transfusions of donated blood components, preventing complications related to transfusions. The creation of patient blood management guidelines is being funded and overseen by the National Blood Authority. Patient blood management enhances patient outcomes by enhancing the patient's medical and surgical care in ways that support and conserve the patient's own blood.
Data Bridge Market Research analyses that the patient blood management market which was USD 12.07 billion in 2021, would rocket up to USD 22.01 billion by 2029, and is expected to undergo a CAGR of 7.80% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Patient Blood Management Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Unit (Blood Components, Whole Blood), Articles (Instruments, Blood Processing Devices, Blood Transfusion Devices, Blood Culture Screening Devices, Diagnostic and Testing Instruments, Blood Storage Devices, Accessories, Syringes and Needles, Vials and Tubes, Blood Bank and Transfusion Software, Software, Assay Kits, Slide Staining, Blood Typing Reagents, Culture Media, Reagents and Kits, Blood Bags), End User (Hospitals, Blood Banks)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Haemonetics Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Terumo Corporation (Japan), Immucor, Inc. (U.S.), B Barun Melsungen AG (Germany), Maco Pharma (France), bioMérieux (France), KANEKA CORPORATION (Japan), Bio-Rad Laboratories Inc. (U.S.), Abbott (U.S.), Grifols, S.A. (Spain), F. Hoffmann-La Roche Ltd (Switzerland), LivaNova PLC (U.K.)
|
|
Market Opportunities
|
|
Market Definition
In order to preserve haemoglobin concentration, maximise hemostasis, and reduce blood loss, patient blood management (PBM) is the timely use of evidence-based medical and surgical ideas.
Patient Blood Management Market Dynamics
Drivers
- Increasing healthcare infrastructure
The patient blood management market is expected to experience dimensional growth from 2022 to 2029 due to the increased support for the value of donated blood from the various verticals of healthcare infrastructure, life sciences, placenta research, and haemoglobin for the advancement of the medical industry.
- Rise in number of blood donors
The number of blood donors is increasing, and lucrative aid is being offered in exchange for donating blood. Due to the real-time solution offered, within this succession, the patient blood management market has moved toward the upside on the success graph due to the rapid increase of awareness given by mushrooming blood donation camps.
- Technological developments
Accelerating pervasiveness of target viruses and forthcoming technological amendments is giving the optimum thrust in the market growth of the patient blood management market.
Opportunities
The possibility for market expansion will come from consumer familiarity with safe and secure blood donation transmission and usage and from market penetration in emerging markets.
Restraints/Challenges
Patient blood management businesses are subject to several restrictions during periods of rapid market growth, including costs associated with acquiring automated patient blood management systems and the potential for data loss. These concerns can limit the market's progress.
This patient blood management market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the patient blood management market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Patient Blood Management Market
The COVID-19 epidemic harmed the companies' sales. Lockdowns caused by the COVID-19 epidemic delayed people getting their health checked, reducing the number of tests performed and reagent sales. However, as governments gradually relax travel restrictions, testing numbers are increasing. Dealing with infectious diseases become major problem around the world since the COVID-19 pandemic. Aside from vaccines and therapeutic medications, there is a growing demand for more precise and simple testing technologies, as well as the expansion of testing structures.
Global Patient Blood Management Market Scope
The patient blood management market is segmented on the basis of articles, unit and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Unit
- Blood Components
- Whole Blood
Articles
- Instruments
- Blood Processing Devices
- Blood Transfusion Devices
- Blood Culture Screening Devices
- Diagnostic and Testing Instruments
- Blood Storage Devices
- Accessories
- Syringes and Needles
- Vials and Tubes
- Blood Bank and Transfusion Software
- Software
- Assay Kits
- Slide Staining
- Blood Typing Reagents
- Culture Media
- Reagents and Kits
- Blood Bags
End User
- Hospitals
- Blood Banks
Patient Blood Management Market Regional Analysis/Insights
The patient blood management market is analysed and market size insights and trends are provided by country, articles, unit and end user as referenced above.
The countries covered in the patient blood management market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North america dominates the patient blood management market due to the eminent healthcare infrastructure.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period 2022 to 2029 due to the focus of various established market players to expand their presence in this particular region and encouraging repayment norms.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Patient Blood Management Market Share Analysis
The patient blood management market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to patient blood management market.
Some of the major players operating in the patient blood management market are:
- Haemonetics Corporation (U.S.)
- Fresenius SE & Co. KGaA (Germany)
- Terumo Corporation (Japan)
- Immucor, Inc. (U.S.)
- B Barun Melsungen AG (Germany)
- Maco Pharma (France)
- bioMérieux (France)
- KANEKA CORPORATION (Japan)
- Bio-Rad Laboratories Inc. (U.S.)
- Abbott (U.S.)
- Grifols, S.A. (Spain)
- F. Hoffmann-La Roche Ltd (Switzerland)
- LivaNova PLC (U.K.)
SKU-